Novoheart Holdings Inc. ("Novoheart" or the "Company") is pleased to announce that the previously announced acquisition by Novomed Limited (the "Purchaser"), a company beneficially owned by entities controlled by Prof. Ronald Li, Dr. Yu Ying Ngan Ng, Chi Wing Ngan and Victor Chang, each a director of the Company, of all the issued and outstanding common shares of Novoheart other than those Novoheart Shares already owned by the Purchaser, by way of a plan of arrangement under the Business Corporations Act (British Columbia) (the "Arrangement") has been completed.

The Arrangement was approved by the Supreme Court of British Columbia in its final order dated November 13, 2020. The Arrangement remains subject to the final approval by the TSX Venture Exchange.

For more detailed press release, please click here.